166 related articles for article (PubMed ID: 34435997)
21. Allogeneic Bone Marrow Mesenchymal Stem Cell Transplantation in Tooth Extractions Sites Ameliorates the Incidence of Osteonecrotic Jaw-Like Lesions in Zoledronic Acid-Treated Rats.
Rodríguez-Lozano FJ; Oñate-Sánchez R; Gonzálvez-García M; Vallés-Bergadá M; Martínez CM; Revilla-Nuin B; Guerrero-Gironés J; Moraleda JM; García-Bernal D
J Clin Med; 2020 May; 9(6):. PubMed ID: 32486396
[TBL] [Abstract][Full Text] [Related]
22. Incidence of and risk factors for medication-related osteonecrosis of the jaw in women with breast cancer with bone metastasis: a population-based study.
Hallmer F; Bjarnadottir O; Götrick B; Malmström P; Andersson G
Oral Surg Oral Med Oral Pathol Oral Radiol; 2020 Sep; 130(3):252-257. PubMed ID: 32536575
[TBL] [Abstract][Full Text] [Related]
23. Hematopoietic Cell Transplantation in Patients with Medication-Related Osteonecrosis of the Jaws.
Mawardi H; Glotzbecker B; Richardson P; Woo SB
Biol Blood Marrow Transplant; 2016 Feb; 22(2):344-348. PubMed ID: 26303103
[TBL] [Abstract][Full Text] [Related]
24. Influence of zoledronic acid on proliferation, migration, and apoptosis of vascular endothelial cells.
Lang M; Zhou Z; Shi L; Niu J; Xu S; Lin W; Chen Z; Wang Y
Br J Oral Maxillofac Surg; 2016 Oct; 54(8):889-893. PubMed ID: 27344431
[TBL] [Abstract][Full Text] [Related]
25. Radiographic bone loss and the risk of medication-related osteonecrosis of the jaw (MRONJ) in multiple myeloma patients-A retrospective case control study.
Wazzan T; Kashtwari D; Almaden WF; Gong Y; Chen Y; Moreb J; Katz J
Spec Care Dentist; 2018 Nov; 38(6):356-361. PubMed ID: 30194738
[TBL] [Abstract][Full Text] [Related]
26. Current Controversies on the Pathogenesis of Medication-Related Osteonecrosis of the Jaw.
Wat WZM
Dent J (Basel); 2016 Oct; 4(4):. PubMed ID: 29563480
[TBL] [Abstract][Full Text] [Related]
27. Prevalence of medication related osteonecrosis of the jaw in patients treated with sequential antiresorptive drugs: systematic review and meta-analysis.
Srivastava A; Nogueras Gonzalez GM; Geng Y; Won AM; Cabanillas ME; Naing A; Myers JN; Li Y; Chambers MS
Support Care Cancer; 2021 May; 29(5):2305-2317. PubMed ID: 33190182
[TBL] [Abstract][Full Text] [Related]
28. Risk Factors for Medication-Related Osteonecrosis of the Jaw-A Binomial Analysis of Data of Cancer Patients from Craiova and Constanta Treated with Zoledronic Acid.
Ciobanu GA; Camen A; Ionescu M; Vlad D; Munteanu CM; Gheorghiță MI; Lungulescu CV; Staicu IE; Sin EC; Chivu L; Mercuț R; Popescu SM
J Clin Med; 2023 May; 12(11):. PubMed ID: 37297941
[TBL] [Abstract][Full Text] [Related]
29. The bisphosphonate zoledronic acid regulates key angiogenesis-related genes in primary human gingival fibroblasts.
Ohlrich EJ; Coates DE; Cullinan MP; Milne TJ; Zafar S; Zhao Y; Duncan WD; Seymour GJ
Arch Oral Biol; 2016 Mar; 63():7-14. PubMed ID: 26658366
[TBL] [Abstract][Full Text] [Related]
30. A systematic review of metastatic cancer presenting in osteonecrosis of the jaws (MC-ONJ) in patients undergoing antiresorptive and/or antiangiogenic therapy for skeletal-related adverse events.
Sacco R; Woolley J; Yates J; Calasans-Maia MD; Akintola O; Patel V
Oral Surg Oral Med Oral Pathol Oral Radiol; 2021 Jun; 131(6):650-659. PubMed ID: 33518491
[TBL] [Abstract][Full Text] [Related]
31. Therapeutic interactions between mesenchymal stem cells for healing medication-related osteonecrosis of the jaw.
Matsuura Y; Atsuta I; Ayukawa Y; Yamaza T; Kondo R; Takahashi A; Ueda N; Oshiro W; Tsukiyama Y; Koyano K
Stem Cell Res Ther; 2016 Aug; 7(1):119. PubMed ID: 27530108
[TBL] [Abstract][Full Text] [Related]
32. Medication-related osteonecrosis of the mandible: an unusual presentation and treatment.
Rothweiler R; Voss PJ; Schmelzeisen R; Metzger MC
Int J Oral Maxillofac Surg; 2021 Apr; 50(4):511-515. PubMed ID: 32847710
[TBL] [Abstract][Full Text] [Related]
33. Fluorescence-guided surgical management of medication-related osteonecrosis of the jaws.
Tomo S; da Cruz TM; Figueira JA; Cunha JLS; Miyahara GI; Simonato LE
Photodiagnosis Photodyn Ther; 2020 Dec; 32():102003. PubMed ID: 32916330
[TBL] [Abstract][Full Text] [Related]
34. Risk-reductive dental strategies for medication related osteonecrosis of the jaw among cancer patients: A systematic review with meta-analyses.
Karna H; Gonzalez J; Radia HS; Sedghizadeh PP; Enciso R
Oral Oncol; 2018 Oct; 85():15-23. PubMed ID: 30220314
[TBL] [Abstract][Full Text] [Related]
35. Photomodulation multiple sessions as a promising preventive therapy for medication-related osteonecrosis of the jaws after tooth extraction in rats.
Statkievicz C; Toro LF; de Mello-Neto JM; de Sá DP; Casatti CA; Issa JPM; Cintra LTA; de Almeida JM; Nagata MJH; Garcia VG; Theodoro LH; Ervolino E
J Photochem Photobiol B; 2018 Jul; 184():7-17. PubMed ID: 29777942
[TBL] [Abstract][Full Text] [Related]
36. Medication-related osteonecrosis of the jaws from once per year intravenous zoledronic acid (Reclast): report of 4 cases.
Lee CY; Suzuki JB
Implant Dent; 2015 Apr; 24(2):227-31. PubMed ID: 25734948
[TBL] [Abstract][Full Text] [Related]
37. Medication-related osteonecrosis of the jaws after tooth extraction in senescent female mice treated with zoledronic acid: Microtomographic, histological and immunohistochemical characterization.
Biguetti CC; De Oliva AH; Healy K; Mahmoud RH; Custódio IDC; Constantino DH; Ervolino E; Duarte MAH; Fakhouri WD; Matsumoto MA
PLoS One; 2019; 14(6):e0214173. PubMed ID: 31199812
[TBL] [Abstract][Full Text] [Related]
38. Multiple myeloma and chemical maxillary osteonecrosis. Can both occur simultaneously?
Junquera S; Álvarez-Yagüe E; Junquera L; Ugalde R; Rúa L
J Stomatol Oral Maxillofac Surg; 2020 Nov; 121(5):523-526. PubMed ID: 31863926
[TBL] [Abstract][Full Text] [Related]
39. Effect of the cumulative dose of zoledronic acid on the pathogenesis of osteonecrosis of the jaws.
Günaldi M; Afsar CU; Duman BB; Kara IO; Tatli U; Sahin B
Oncol Lett; 2015 Jul; 10(1):439-442. PubMed ID: 26171047
[TBL] [Abstract][Full Text] [Related]
40. Effectiveness of treatments for medication-related osteonecrosis of the jaw: A systematic review and meta-analysis.
El-Rabbany M; Sgro A; Lam DK; Shah PS; Azarpazhooh A
J Am Dent Assoc; 2017 Aug; 148(8):584-594.e2. PubMed ID: 28527518
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
